David Sheehan
Psychiatry · Tampa, FLNPI 1437263365
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.9%), speaking fees and royalties or licence payments — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Janssen Research & Development, LLC at 28.5% of the total. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $3106.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$180K
- Sage Therapeutics, LLC$154K
- Axsome Therapeutics, Inc.$84K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$71K
- Eisai Inc.$35K
- Johnson & Johnson$24K
- plus $82K from 14 others
Across 40 payments — averaging $8080.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$63K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$62K
- Vanda Pharmaceuticals Inc.$54K
- AbbVie$32K
- Livanova USA, Inc.$31K
- H. Lundbeck A S$24K
- plus $58K from 10 others
What the payments were for
- Royalty or licence$143,43823%
- Consulting fees$308,10949%
- Speaking & faculty fees$162,96826%
- Travel & lodging$12,0232%
- Food & beverage$4,1261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 13 | $179,937 |
| Sage Therapeutics, LLC | 41 | $153,974 |
| Axsome Therapeutics, Inc. | 4 | $84,310 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $71,365 |
| Eisai Inc. | 42 | $34,554 |
| Johnson & Johnson | 36 | $24,040 |
| GSK | 2 | $20,339 |
| Sunovion Pharmaceuticals Inc. | 24 | $13,830 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $8,888 |
| Biohaven Pharmaceuticals, Inc. | 9 | $8,150 |
| Shionogi Inc | 2 | $7,500 |
| AbbVie(2 entities) | 4 | $6,115 |
| Orion Corporation | 2 | $4,770 |
| Corcept Therapeutics | 1 | $4,500 |
| Idorsia Pharmaceuticals US Inc | 2 | $2,505 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $2,500 |
| Otsuka America Pharmaceutical, Inc. | 1 | $1,440 |
| Biogen | 3 | $966 |
| Acadia Pharmaceuticals Inc | 1 | $500 |
| USWM, LLC | 1 | $480 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$630,664 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paroxetine Hcl | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Tampa
- Jamie FernandezTampa$418K
- Hardeep SinghTampa$374K
- Kenneth PagesTampa$274K
- Chetan GandhyTampa$94K
- Deborah Knudson GonzalezTampa$81K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.